Elvira Olaso

2.1k total citations
30 papers, 1.7k citations indexed

About

Elvira Olaso is a scholar working on Immunology and Allergy, Molecular Biology and Hepatology. According to data from OpenAlex, Elvira Olaso has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology and Allergy, 14 papers in Molecular Biology and 12 papers in Hepatology. Recurrent topics in Elvira Olaso's work include Cell Adhesion Molecules Research (16 papers), Liver physiology and pathology (11 papers) and Proteoglycans and glycosaminoglycans research (6 papers). Elvira Olaso is often cited by papers focused on Cell Adhesion Molecules Research (16 papers), Liver physiology and pathology (11 papers) and Proteoglycans and glycosaminoglycans research (6 papers). Elvira Olaso collaborates with scholars based in Spain, United States and Germany. Elvira Olaso's co-authors include Scott L. Friedman, Li‐Hsien Wang, Hsin Chieh Lin, Francis J. Eng, Kazuo Ikeda, Fernando Vidal‐Vanaclocha, Lie-Ming Xu, Juan-Pablo Labrador, Rüdiger Klein and Beatriz Arteta and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Hepatology.

In The Last Decade

Elvira Olaso

30 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elvira Olaso Spain 18 630 615 471 377 355 30 1.7k
Alessandra Marchetti Italy 21 244 0.4× 1.3k 2.1× 748 1.6× 194 0.5× 269 0.8× 44 2.0k
Vittoria Cioce United States 10 249 0.4× 842 1.4× 337 0.7× 205 0.5× 280 0.8× 11 1.3k
Lucia Fallavollita Canada 17 294 0.5× 669 1.1× 685 1.5× 114 0.3× 120 0.3× 23 1.5k
Michiya Kawaguchi Japan 14 164 0.3× 794 1.3× 680 1.4× 254 0.7× 98 0.3× 25 1.8k
Giuseppina De Petro Italy 25 213 0.3× 1.1k 1.8× 236 0.5× 191 0.5× 115 0.3× 65 1.8k
Pablo Colorado United States 12 548 0.9× 998 1.6× 254 0.5× 70 0.2× 156 0.4× 21 2.0k
Masayuki Koizumi Japan 25 136 0.2× 1.6k 2.6× 1.1k 2.4× 263 0.7× 183 0.5× 53 3.0k
Mayshan Ghiassi United States 11 179 0.3× 1.2k 1.9× 566 1.2× 69 0.2× 203 0.6× 13 1.7k
Ryoji Hamanaka Japan 18 120 0.2× 1.2k 2.0× 613 1.3× 112 0.3× 792 2.2× 34 1.8k
Vicki L. Rothman United States 25 375 0.6× 1.4k 2.3× 383 0.8× 44 0.1× 305 0.9× 48 2.1k

Countries citing papers authored by Elvira Olaso

Since Specialization
Citations

This map shows the geographic impact of Elvira Olaso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elvira Olaso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elvira Olaso more than expected).

Fields of papers citing papers by Elvira Olaso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elvira Olaso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elvira Olaso. The network helps show where Elvira Olaso may publish in the future.

Co-authorship network of co-authors of Elvira Olaso

This figure shows the co-authorship network connecting the top 25 collaborators of Elvira Olaso. A scholar is included among the top collaborators of Elvira Olaso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elvira Olaso. Elvira Olaso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Apraiz, Aintzane, Aitor Benedicto, Joana Márquez, et al.. (2020). Innate Lymphoid Cells in the Malignant Melanoma Microenvironment. Cancers. 12(11). 3177–3177. 5 indexed citations
2.
Badiola, Iker, et al.. (2020). Silencing of sinusoidal DDR1 reduces murine liver metastasis by colon carcinoma. Scientific Reports. 10(1). 18398–18398. 19 indexed citations
4.
Benedicto, Aitor, et al.. (2019). Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance. Pancreas. 48(4). 555–567. 12 indexed citations
5.
Benedicto, Aitor, et al.. (2017). Ocoxin oral solution® as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver. Oncology Letters. 13(6). 4002–4012. 15 indexed citations
6.
7.
Márquez, Joana, et al.. (2015). Ocoxin® oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice. Oncology Reports. 35(3). 1265–1272. 19 indexed citations
8.
Olaso, Elvira, Beatriz Arteta, Aitor Benedicto, Olatz Crende, & Scott L. Friedman. (2011). Loss of Discoidin Domain Receptor 2 Promotes Hepatic Fibrosis after Chronic Carbon Tetrachloride through Altered Paracrine Interactions between Hepatic Stellate Cells and Liver-Associated Macrophages. American Journal Of Pathology. 179(6). 2894–2904. 42 indexed citations
9.
Olaso, Elvira, Hsin‐Chieh Lin, Li‐Hsien Wang, & Scott L. Friedman. (2011). Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling. PubMed. 4(1). 5–5. 59 indexed citations
10.
Salado, Clarisa, Elvira Olaso, María Valcárcel, et al.. (2011). Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18. Journal of Translational Medicine. 9(1). 59–59. 47 indexed citations
11.
Badiola, Iker, Elvira Olaso, Olatz Crende, Scott L. Friedman, & Fernando Vidal‐Vanaclocha. (2011). Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut. 61(10). 1465–1472. 60 indexed citations
12.
Badiola, Iker, et al.. (2007). Implication of discoidin domain receptors in the activation of hepatic stellate cells during liver metastasis. Cancer Research. 67. 2457–2457. 1 indexed citations
13.
Badiola, Iker, Yves A. DeClerck, Steven J. Wall, Fernando Vidal‐Vanaclocha, & Elvira Olaso. (2006). The role of DDR1 and DDR2 collagen receptors in tumor progression. Cancer Research. 66. 394–394. 1 indexed citations
14.
Olaso, Elvira, Clarisa Salado, Eider Egilegor, et al.. (2003). Proangiogenic Role of Tumor–Activated Hepatic Stellate Cells in Experimental Melanoma Metastasis. Hepatology. 37(3). 674–685. 153 indexed citations
15.
Olaso, Elvira & Fernando Vidal‐Vanaclocha. (2003). Use of Tumor-Activated Hepatic Stellate Cell as a Target for the Preclinical Testing of Anti-Angiogenic Drugs Against Hepatic Tumor Development. Humana Press eBooks. 85. 79–86. 4 indexed citations
16.
Ikeda, Kazuo, Li‐Hsien Wang, Richard Torres, et al.. (2002). Discoidin Domain Receptor 2 Interacts with Src and Shc following Its Activation by Type I Collagen. Journal of Biological Chemistry. 277(21). 19206–19212. 108 indexed citations
17.
Mendoza, Lorea, et al.. (2002). Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium. Hepatology. 35(5). 1104–1116. 29 indexed citations
18.
Olaso, Elvira, Kazuo Ikeda, Francis J. Eng, et al.. (2001). DDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cells. Journal of Clinical Investigation. 108(9). 1369–1378. 207 indexed citations
19.
Mendoza, Lorea, et al.. (1998). Mannose receptor‐mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver. Journal of Cellular Physiology. 174(3). 322–330. 3 indexed citations
20.
Olaso, Elvira, et al.. (1997). Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology. 26(3). 634–642. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026